Seven ways the Community Advisory Committee strengthens HIV research
Here are the seven ways that the CTN works towards the meaningful involvement of people...
Learn MoreJanuary 5, 2021
Treating liver disease in people living with HIV
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
Learn More
New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Learn More
Examining the results of CTN 297: Black PRAISE
The Black PRAISE team have pioneered a novel intervention aimed at reducing HIV-related stigma while strengthening the HIV knowledge base among Black church congregations in Ontario
Learn More
Engage-COVID-19
New funding for CTN 300-2 will allow the study team to document COVID-19 infection, immunity, and related determinants in gay, bisexual, and other men who have sex with men
Learn More
OPAL-COVID-19 Study
Dr. Bertrand Lebouché joins the creators of the health app Opal to repurpose it for COVID-19 patients recovering from home
Learn More
A collaborative approach to women-centred HIV care
The CTN 262 CHIWOS study have launched an all-encompassing Women-Centred HIV Care model and two toolkits
Learn More
The CTN and COVID-19
At the CTN, we are proud to be a conduit for the rapid implementation of national co-ordinated COVID-19 trials
Learn More
Here’s what we know about COVID-19 & HIV
Many questions remain about COVID-19 and what it means for people living with HIV. We explore the research so far
Learn More